metricas
covid
Neurología (English Edition) Post-authorisation study of eslicarbazepine as treatment for drug-resistant epil...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results
Estudio postautorización de la eslicarbazepina en el tratamiento de epilepsias farmacorresistentes: resultados preliminares
A. Massot, R. Vivanco, A. Principe, J. Roquer, R. Rocamora
Corresponding author
RRocamora@parcdesalutmar.cat

Corresponding author.
Unidad de Epilepsia, Servicio de Neurología, Hospital del Mar, Barcelona, Spain
Read
6181
Times
was read the article
1327
Total PDF
4854
Total HTML
Share statistics
Article information
ISSN: 21735808
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 41 2 43
2025 11 279 32 311
2025 10 119 13 132
2025 9 85 26 111
2025 8 74 14 88
2025 7 151 6 157
2025 6 76 7 83
2025 5 81 3 84
2025 4 65 3 68
2025 3 86 11 97
2025 2 85 17 102
2025 1 53 17 70
2024 12 60 20 80
2024 11 44 7 51
2024 10 33 11 44
2024 9 29 8 37
2024 8 46 14 60
2024 7 54 14 68
2024 6 29 11 40
2024 5 15 6 21
2024 4 28 18 46
2024 3 41 8 49
2024 2 26 8 34
2024 1 17 7 24
2023 12 24 7 31
2023 11 30 8 38
2023 10 41 16 57
2023 9 18 6 24
2023 8 28 6 34
2023 7 13 11 24
2023 6 37 6 43
2023 5 47 8 55
2023 4 28 1 29
2023 3 24 3 27
2023 2 27 10 37
2023 1 19 6 25
2022 12 17 9 26
2022 11 38 17 55
2022 10 22 23 45
2022 9 26 15 41
2022 8 36 9 45
2022 7 18 8 26
2022 6 18 5 23
2022 5 19 20 39
2022 4 12 6 18
2022 3 26 11 37
2022 2 28 8 36
2022 1 51 11 62
2021 12 21 18 39
2021 11 22 12 34
2021 10 35 11 46
2021 9 38 20 58
2021 8 18 8 26
2021 7 13 7 20
2021 6 25 11 36
2021 5 20 8 28
2021 4 20 15 35
2021 3 26 9 35
2021 2 26 8 34
2021 1 11 8 19
2020 12 14 15 29
2020 11 15 7 22
2020 10 5 3 8
2020 9 20 12 32
2020 8 11 8 19
2020 7 25 11 36
2020 6 24 7 31
2020 5 20 11 31
2020 4 24 1 25
2020 3 23 7 30
2020 2 20 6 26
2020 1 23 19 42
2019 12 13 3 16
2019 11 16 6 22
2019 10 25 16 41
2019 9 44 9 53
2019 8 19 6 25
2019 7 13 21 34
2019 6 27 16 43
2019 5 87 49 136
2019 4 42 13 55
2019 3 15 4 19
2019 2 14 4 18
2019 1 4 3 7
2018 12 11 5 16
2018 11 13 7 20
2018 10 22 8 30
2018 9 45 6 51
2018 8 9 11 20
2018 7 8 3 11
2018 6 22 0 22
2018 5 11 2 13
2018 4 24 0 24
2018 3 8 2 10
2018 2 6 5 11
2018 1 7 0 7
2017 12 6 2 8
2017 11 12 2 14
2017 10 13 2 15
2017 9 22 5 27
2017 8 19 4 23
2017 7 10 2 12
2017 6 22 5 27
2017 5 26 3 29
2017 4 13 3 16
2017 3 12 14 26
2017 2 22 2 24
2017 1 21 3 24
2016 12 34 7 41
2016 11 37 4 41
2016 10 44 7 51
2016 9 91 5 96
2016 8 62 4 66
2016 7 35 2 37
2016 6 43 10 53
2016 5 44 6 50
2016 4 42 15 57
2016 3 45 22 67
2016 2 45 12 57
2016 1 37 8 45
2015 12 26 4 30
2015 11 24 6 30
2015 10 40 15 55
2015 9 35 11 46
2015 8 45 7 52
2015 7 45 5 50
2015 6 26 4 30
2015 5 27 10 37
2015 4 39 18 57
2015 3 40 15 55
2015 2 42 5 47
2015 1 58 7 65
2014 12 57 17 74
2014 11 32 9 41
2014 10 55 9 64
2014 9 48 8 56
2014 8 46 10 56
2014 7 36 12 48
2014 6 32 10 42
2014 5 20 11 31
2014 4 27 12 39
2014 3 29 19 48
Show all

Follow this link to access the full text of the article